Prostate cancer is one of the most common cancers among men in the United States, second only to skin cancer. Many people have heard about prostate cancer, but not everyone fully understands it. The good news is that with early detection and advancements in treatment,...
A test for the splice-variant AR-V7, Oncotype Dx AR-V7 Nucleus Detect (Genomic Health, Inc.), has become commercially available. This Commentary will focus on the clinical significance of test results — their predictive and prognostic value. The Major Foundation...
